|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 1 (January 1), 2000:
pp. 173-179
Protein S secretion differences of missense mutants account
for phenotypic heterogeneity
Yolanda Espinosa-Parrilla,
Tomio Yamazaki,
Nùria Sala,
Björn Dahlbäck, and
Pablo García de Frutos
From the Department of Clinical Chemistry, Lund University,
University Hospital, Malmö, Sweden; and Centre de Genètica
Mèdica i Molecular, Institut de Recerca Oncològica (IRO),
Barcelona, Spain.
To elucidate the molecular background for the heterogeneity in
protein S plasma concentrations observed in protein S deficient individuals, the in vitro synthesis of recombinant protein S missense mutants was investigated. Six different naturally occurring mutations identified in the protein S gene (PROS1) of thrombosis patients were reproduced in protein S cDNA by site directed mutagenesis. Two
mutants, G441C and Y444C (group A), were associated with low total
plasma concentration of protein S. Modestly low protein S was found in
families with R520G and P626L (group B) mutants. T57S and I518M (group
C), which was associated with marginally low protein S, did not
segregate with protein S deficiency in the respective families, raising
doubts as to whether they were causative mutations or rare neutral
variants. The 6 protein S mutants were transiently expressed in COS 1 cells. The Y444C mutant showed the lowest level of secretion (2.5%)
followed by the G441C mutant (40%). Group B demonstrated around 50%
reduction in secretion, whereas group C mutants showed normal
secretion. Pulse-chase experiments demonstrated impaired protein S
processing with intracellular degradation and decreased secretion into
the culture media of group A and B mutants. Interestingly, there was a
good correlation between in vitro secretion and the concentration of
free protein S in the plasma of heterozygous carriers. These results
demonstrate impaired protein S secretion to be an important mechanism
underlying hereditary protein S deficiency and that variations in
protein secretion is a major determinant of the phenotypic
heterogeneity observed in protein S deficiency. (Blood.
2000;95:173-179)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. Hurtado, X. Munoz, M. C. Mulero, G. Navarro, P. Domenech, P. Garcia de Frutos, M. Perez-Riba, and N. Sala
Functional characterization of twelve natural PROS1 mutations associated with anticoagulant protein S deficiency
Haematologica,
April 1, 2008;
93(4):
574 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. V. Denis, S. J. Roberts, T. M. Hackeng, and P. J. Lenting
In Vivo Clearance of Human Protein S in a Mouse Model: Influence of C4b-Binding Protein and the Heerlen Polymorphism
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2005;
25(10):
2209 - 2215.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Rezende, R. E. Simmonds, and D. A. Lane
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex
Blood,
February 15, 2004;
103(4):
1192 - 1201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Borgel, J.-L. Reny, D. Fischelis, S. Gandrille, J. Emmerich, J.-N. Fiessinger, and M. Aiach
Cleaved Protein S (PS), Total PS, Free PS, and Activated Protein C Cofactor Activity as Risk Factors for Venous Thromboembolism
Clin. Chem.,
April 1, 2003;
49(4):
575 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yamazaki, G. A. F. Nicolaes, K. W. Sorensen, and B. Dahlback
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype
Blood,
September 18, 2002;
100(7):
2515 - 2521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. K. Giri, T. Yamazaki, N. Sala, B. Dahlback, and P. G. de Frutos
Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors
Blood,
July 15, 2000;
96(2):
523 - 531.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
